Clinical Trial Update: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines [Phase 3]

View source ↗

Summary

An ongoing Phase 3 study evaluating Zasocitinib in adults with psoriatic arthritis, including participants who have and have not previously been treated with bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Zasocitinib (Zasocitinib)

Snippet

Sponsor: Takeda | Conditions: Psoriatic Arthritis | Phase 3 | Status: RECRUITING